We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

2ing

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2ing.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2ing.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2ing| PDB=2ing | SCENE= }}
{{STRUCTURE_2ing| PDB=2ing | SCENE= }}
-
'''X-ray Structure of the BRCA1 BRCT mutant M1775K'''
+
===X-ray Structure of the BRCA1 BRCT mutant M1775K===
-
==Overview==
+
<!--
-
A number of germ-line mutations in the BRCA1 gene confer susceptibility to breast and ovarian cancer. However, it remains difficult to determine whether many single amino-acid (missense) changes in the BRCA1 protein that are frequently detected in the clinical setting are pathologic or not. Here, we used a combination of functional, crystallographic, biophysical, molecular and evolutionary techniques, and classical genetic segregation analysis to demonstrate that the BRCA1 missense variant M1775K is pathogenic. Functional assays in yeast and mammalian cells showed that the BRCA1 BRCT domains carrying the amino-acid change M1775K displayed markedly reduced transcriptional activity, indicating that this variant represents a deleterious mutation. Importantly, the M1775K mutation disrupted the phosphopeptide-binding pocket of the BRCA1 BRCT domains, thereby inhibiting the BRCA1 interaction with the proteins BRIP1 and CtIP, which are involved in DNA damage-induced checkpoint control. These results indicate that the integrity of the BRCT phosphopeptide-binding pocket is critical for the tumor suppression function of BRCA1. Moreover, this study demonstrates that multiple lines of evidence obtained from a combination of functional, structural, molecular and evolutionary techniques, and classical genetic segregation analysis are required to confirm the pathogenicity of rare variants of disease-susceptibility genes and obtain important insights into the underlying pathogenetic mechanisms.European Journal of Human Genetics advance online publication, 20 February 2008; doi:10.1038/ejhg.2008.13.
+
The line below this paragraph, {{ABSTRACT_PUBMED_18285836}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 18285836 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_18285836}}
==About this Structure==
==About this Structure==
Line 34: Line 38:
[[Category: Repeat]]
[[Category: Repeat]]
[[Category: Zinc-finger]]
[[Category: Zinc-finger]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 07:41:28 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 2 20:54:35 2008''

Revision as of 17:54, 2 July 2008

Image:2ing.png

Template:STRUCTURE 2ing

X-ray Structure of the BRCA1 BRCT mutant M1775K

Template:ABSTRACT PUBMED 18285836

About this Structure

2ING is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach., Tischkowitz M, Hamel N, Carvalho MA, Birrane G, Soni A, van Beers EH, Joosse SA, Wong N, Novak D, Quenneville LA, Grist SA, Nederlof PM, Goldgar DE, Tavtigian SV, Monteiro AN, Ladias JA, Foulkes WD, Eur J Hum Genet. 2008 Feb 20;. PMID:18285836

Page seeded by OCA on Wed Jul 2 20:54:35 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2ing"
Personal tools